COVID-19 vaccines for kids 5 to 11 get final endorsement by CDC

By: Laura Olson - November 3, 2021 12:08 pm

UPS employees move one of two shipping containers containing the first shipments of the Pfizer and BioNTech COVID-19 vaccine inside a sorting facility in Louisville, Kentucky. The flight originated in Lansing, Michigan. Photo by Michael Clevenger— Pool/Getty Images.

WASHINGTON — The Centers for Disease Control and Prevention has signed off on giving Pfizer’s COVID-19 vaccine to all kids ages 5 to 11, a final decision that means those children can begin receiving shots as soon as Wednesday.

Vials of the pediatric version of the vaccine have already been shipped to states, so they are ready for use following the CDC action.

Making the 28 million American children in that age group eligible for a COVID-19 vaccine for the first time is projected to help accelerate the current decline in infections nationally, and reduce the ability of any new variants of the virus to take hold.

A CDC estimate shared ahead of Tuesday’s vote by the Advisory Committee on Immunization Practices said that vaccinating 5- to 11-year-olds could reduce infections by 8% between now and the end of March.

“I feel that I have a responsibility to make the vaccine available,” said Dr. Beth Bell, a clinical professor at the University of Washington’s School of Public Health and a member of the advisory panel. “If I had a grandchild, I would certainly get that grandchild vaccinated as soon as possible.”

The final endorsement came Tuesday night from CDC Director Dr. Rochelle Walensky.

Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.

Laura Olson

Laura covers the nation's capital as a senior reporter for States Newsroom, a network of nonprofit outlets that includes Minnesota Reformer. Her areas of coverage include politics and policy, lobbying, elections, and campaign finance.